|

TCC1727 tablet 120mg Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Beijing Tide Pharmaceutical Co., Ltd1

Indications

  • Gastric (Stomach) Cancer1
  • Solid Cancers1
  • NSCLC (Advanced Non-small Cell Lung Cancer)1
  • Malignant Melanoma1
  • Endometrial Cancer1

Other1 trial

An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.